Assessment of systemic vasculitis

Autoimmunity Reviews

Volumn 8, Issue 2, 2008, Pages 170-175

  Miller, Anne ^a   Basu, Neil ^b   Luqmani, Raashid ^c  

^a NUFFIELD ORTHOPAEDIC CENTRE   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

ANCA; BVAS; Imaging; Systemic vasculitis; VDI

Indexed keywords

BIOLOGICAL MARKER; CORTICOSTEROID; CYCLOPHOSPHAMIDE; FLUORODEOXYGLUCOSE F 18; NEUTROPHIL CYTOPLASMIC ANTIBODY;

BLOOD VESSEL; COLOR ULTRASOUND FLOWMETRY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DISEASE ACTIVITY; DRUG MEGADOSE; EARLY DIAGNOSIS; GIANT CELL ARTERITIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; QUALITY OF LIFE; REVIEW; SYSTEMIC VASCULITIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; HUMANS; QUALITY OF LIFE; VASCULITIS;

EID: 56349096980     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2008.07.001     Document Type: Review

References (40)

1. Jayne D., Rasmussen N., Andrassy K., Bacon P., Tervaert J.W., Dadoniené J., et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 349 (2003) 36-44
2. Booth A.D., Almond M.K., Burns A., Ellis P., Gaskin G., Neild G.H., et al. Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis 41 (2003) 776-784
3. Fries J.F., Hunder G.G., Bloch D.A., et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary. Arthritis Rheum 33 (1990) 1135-1136
4. Rao J.K., Allen N.B., and Pincus T. Limitations of the 1990 American College of Rheumatology classification criteria in the diagnosis of vasculitis. Ann Intern Med 129 (1998) 345-352
5. Flossmann O., Bacon P., de Groot D., Jayne K., Rasmussen N., Seo P., et al. Development of comprehensive disease assessment in systemic vasculitis. Ann Rheum Dis 66 (2007) 283-292
6. Mukhtyar C., Guillevin L., Cid M.C., Dasgupta B., de Groot K., Gross W., et al. EULAR Recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 15 (2008) [Electronic publication ahead of print]
7. Mukhtyar C., Guillevin L., Cid M.C., Dasgupta B., de Groot K., Gross W., et al. EULAR Recommendations for the management of large vessel vasculitis. Ann Rheum Dis 15 (2008) [Electronic publication ahead of print]
8. Adu D., Howie A.J., Scott D.G., Bacon P.A., McGonigle R.J., and Michael J. Polyarteritis and the kidney. Q J Med 62 (1987) 221-237
9. Wiik A. Systemic small vessel vasculitis: pathophysiological aspects of antineutrophil cytoplasm antibodies (ANCA). A review on recent findings. Autoimmun Rev Suppl 1 (2004) S51-S53
10. Xiao H., Heeringa P., Hu P., Liu Z., Zhao M., Aratani Y., et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 110 (2002) 955-963
11. Blank M., Tomer Y., Stein M., Kopolovic J., Wiik A., Meroni P.L., et al. Immunization with anti-neutrophil cytoplasmic antibody (ANCA) induces the production of mouse ANCA and perivascular lymphocyte infiltration. Clin Exp Immunol 102 (1995) 120-130
12. Andrews M., Edmunds M., Campbell A., Walls J., and Feehally J. Systemic vasculitis in the 1980s-is there an increasing incidence of Wegener's granulomatosis and microscopic polyarteritis?. J R Coll Physicians Lond 24 (1990) 284-288
13. McLaren J.S., Stimson R.H., McRorie E.R., Coia J.E., and Luqmani R.A. The diagnostic value of anti-neutrophil cytoplasmic antibody testing in a routine clinical setting. QJM 94 (2001) 615-621
14. van der Woude F.J., Rasmussen N., Lobatto S., Wiik A., Permin H., van Es L.A., et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 23 (1985) 425-429
15. Koutantji M., Harrold E., Lane S.E., Pearce S., Watts R.A., and Scott D.G.I. Investigation of quality of life, mood, pain disability and disease status in primary systemic vasculitis. Arthritis Rheum 49 (2003) 826-837
16. Del Buono E.A., and Flint A. Diagnostic usefulness of nasal biopsy in Wegener's granulomatosis. Human Pathol 22 (1991) 107-110
17. De Vita S., Quartuccio L., and Fabris M. Hepatitis C virus infection, mixed crioglobulinemia cryoglobulinemia and BLyS upregulation: targeting the infectious trigger, the autoimmune response, or both?. Autoimmun Rev (Jun. 24, 2008) [Electronic publication ahead of print]
18. Trepo C., and Thivolet J. Hepatitis associated antigen and periarteritis nodosa (PAN). Vox Sang 19 (1970) 410-411
19. Jennette J.C., Falk R.J., Andrassy K., Bacon P.A., Churg J., Gross W.L., et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37 (1994) 187-192
20. McPhaul Jr. J.J., and Dixon F.J. Characterization of human anti-glomerular basement membrane antibodies eluted from glomerulonephritic kidneys. J Clin Invest 49 (1970) 308-317
21. Rao J.K., Weinberger M., Oddone E.Z., Allen N.B., landsman P., and Reussner J.R. The role of antineutrophil cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener granulomatosis. A literature review and meta-analysis. Ann Intern Med 123 (1995) 925-932
22. Tervaert J.W., Huitema M.G., Hené R.J., Sluiter W.J., The T.H., van der Hem G.K., et al. Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet 336 (1990) 709-711
23. Birck R., Schmitt W.H., Kaelsch I.A., and van der Woude F.J. Serial ANCA determinations for monitoring disease activity in patients with ANCA-associated vasculitis: systematic review. Am J Kidney Dis 47 (2006) 15-23
24. Faurschou M., Sorensen I.J., Mellemkjaer I., Loft A.G., Thomsen B.S., Tvede N., et al. Malignancies in Wegener's granulomatosis: incidence and relation to cyclophosphamide therapy in a cohort of 293 patients. J Rheumatol 35 (2008) 100-105
25. Haubitz M., Ehlerding C., Kamino K., Koch K.M., and Brunkhorst R. Reduced gonadal toxicity after i.v. cyclophosphamide administration in patients with nonmalignant diseases. Clin Nephrol 49 (1998) 19-23
26. Kloczko J., Kuryliszyn-Moskal A., Bernacka K., Bielawiec M., Cylwik B., and Radziwon P. Von Willebrand factor antigen in assessment of vasculitis in patients with connective tissue diseases. Clin Rheumatol 13 (1994) 34-38
27. Savage C., and Williams J. Anti-endothelial cell antibodies in vasculitis. J Am Soc Nephrol 18 (2007) 2424-2426
28. Di Lorenzo G., Pacor M.L., Mansueto P., et al. Circulating levels of soluble adhesion molecules in patients with ANCA-associated vasculitis. J Nephrol 17 (2004) 800-807
29. Sanders J.S., Huitema M.G., Hanemaaijer R., van Goor H., Kallenberg C.G., and Stegeman C.A. Urinary matrix metalloproteinases reflect renal damage in anti-neutrophil cytoplasm autoantibody-associated vasculitis. Am J Physiol 293 (2007) 927-1934
30. Choe Y.H., Kim D.K., Koh E.M., Do Y.S., and Lee W.R. Takayasu arteritis: diagnosis with MR imaging and MR angiography in acute and chronic active stages. J Magn Reson Imaging 10 (1999) 751-757
31. Bley T.A., Markl M., Schlep M., Uhl M., Frydrychowicz A., Vaith P., et al. Mural inflammatory hyperenhancement in MRI of giant cell (temporal) arteritis resolves under corticosteroid treatment. Rheumatol 47 (2008) 65-67
32. Rav-Acha M., Plot L., Peled N., and Amital H. Coronary involvement in Takayasu's arteritis. Autoimmun Rev 6 (2007) 566-571
33. Schmidt W.A., Kraft H.E., Vorpahl K., Volker L., and Gromnica-Ihle E.J. Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med 337 (1997) 1336-1342
34. Karassa F.B., Matsagas M.I., Schmidt W.A., and Ioannidis J.P.A. Meta-analysis: test performance of ultrasonography for giant cell arteritis. Ann Intern Med 142 (2005) 359-369
35. Karahaliou M., Vaiopoulos G., Papaspyrou S., Kanakis M.A., Revenal K., Sfikakis, and P.P. Colour duplex sonography of temporal arteries before decision for biopsy: a prospective study in 55 patients with suspected giant cell arteritis. Arthritis Res Ther 8 (2006) R116
36. Salvarani C., Silingardi M., Ghirarduzzi A., Lo Scocco G., Machioni P., Bajocchi G., et al. Is duplex ultrasonography useful for the diagnosis of giant-cell arteritis?. Ann Intern Med 137 (2002) 232-238
37. Brodmann M., Lipp R.W., Passath A., Seinost G., Pabst E., and Pilger E. the role of 2-18F-fluoro-2-deoxy-d-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries. Rheumatology 43 (2004) 675-676
38. Walter M.A., Melzer R.A., Schindler C., Muller-Brand J., Tyndall A., and Nitzsche E.U. The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. Eur J Nucl Med Mol Imaging 32 (2005) 674-681
39. Park J.H., Chung J.W.M., Lee K.W., Park Y.B., and Han M.C. CT angiography of Takayasu Arteritis: comparison with conventional angiography. J Vasc Interv Radiol 8 (1997) 393-400
40. Gotway M.B., Araoz P.A., Macedo T.A., Stanson A.W., Higgins C.B., Ring E.J., et al. Imaging findings in Takayasu's Arteritis. Am J Roentgenol 184 (2005) 1945-1950